COMPOSITION:
Contains per gram powder:
Enrofloxacin .................................................. 500 mg.
Carrier ad........................................................ 1 g.
Description:
Almost white granular particle
Pharmacological action:
Enrofloxacin is a fluoroquinolone antibiotic which acts by inhibition of bacterial DNA-gyrase. It is administered to cattle, pigs, and chickens to control bacterial infections caused by sensitiveorganisms. Obviously inhibit the activity of Coliform, Staphylococcus aureus, Salmonella,Vibriosis, Mycoplasma, etc. It exerts positively strong effects against intestinal diseases and breath system diseases.
Adverse reaction: no prescription
Indication:
Fluoroquinolone. Used to treat and control chronic respiratory diseases in poultry, septic colibacillosis, malignant rhinitis, Pasteurella, salmonellosis, staphylocosis, swine dysentery, endemic epidemic pneumonia, swine hydropsy, cattle colibacillosis and mastitis.
Dosage and Ministration:
Mix with the feed basing on effective ingredient Enrofloxacin.
Per1000kg feed contains:
Prevention:Piglet: 100g ;Growing pig: 80 - 100mg/kg
Treatment:Pig: 150 - 200g, Using for 5 - 7 continuous days
Precaution:can not be used in laying periodDo not recommend to use in sows during pregnancy and lactation.
Withdrawal period:
pig:10 days
Packing: 10kg/drum
Storage:Keepsealed and stored in cool and dry place Validity

• We, Pionner technology is a leading pharmaceuticals wholesaler based in China, distributing a full range of branded, comparator, controlled and rare to find pharmaceutical products with almost 20years for exporting APIs and Finished Drugs with professional mature team.
• We are not only the raw materials distributors, but also have a mature animal drug production base in China. We can source products for export from all major International (Chinese-based) and Chinese Pharmaceutical manufacturers. We accept the OEM for finished drugs, and also agree with different countries register finished drugs (Human and Vet).
• Our main focus is to supply comparator products and drugs used to combat life-threatening conditions – at competitive prices to various institutions and organizations in underdeveloped and developing countries of Asia, Middle East, Africa and South America, etc.